New Drug Applications

FDA Grants Tentative Approval for Liquidia’s Yutrepia (treprostinil) Inhalation Powder

5 years ago
by David Miller
980 Views
Written by David Miller

First dry-powder formulation of treprostinil to meet criteria required for FDA approval Final FDA approval may occur in October 2022 or earlier upon resolution of on-going litigation MORRISVILLE, N.C., Nov. 08, 2021 (GLOBE NEWSWIRE) –…Original Article

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts
[mwai_chat window="true" fullscreen="true"]